News Alert

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

GSK headquarters
GSK was one of two drugmakers to issue refunds to 340B covered entities, according to notices posted on a government regulatory site.
GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospital Registration Waiver Withdrawal Could Draw Legal Challenge

Dept. of Health and Human Services building and signage
Hospital advocates said HRSA's recent decision to end a 340B program waiver for hospitals could draw legal challenges.
The recent end of a 340B program waiver for hospitals is wrong, hurts hospitals and their patients, and is bound [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Arkansas Defends Enforcement of 340B Contract Pharmacy Law in Drugmaker Suit

Arkansas Insurance Department office sign
The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.
Federal courts should allow enforcement of Arkansas’ 340B contract pharmacy law to continue unimpeded, an attorney representing Arkansas told a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B…or not to B…?

Robin George headshot

SPONSORED CONTENT

The 340B program, enacted in 1992, enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.

In 2010, the 340B program was expanded under the Affordable Care Act, allowing covered entities to contract with an unlimited number

Read More »

340B Hospitals’ Community Benefit Surges in 2020, Says Hospital-Backed Report

AHA
The American Hospital Association published a study that found 340B hospitals' community benefit increased significantly in 2020.
The community benefits provided by 340B hospitals surged by $16.5 billion, or 24%, in the latest year analyzed by a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA To End Waiver for Some Offsite 340B Hospital Locations, Provides Grace Period

HRSA building and signage
HRSA confirmed it will end a pandemic-era waiver program that allowed 340B drug use in certain offsite hospital locations.
The Health Resources and Services Administration (HRSA) confirmed today it is ending a 340B program waiver issued early in the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provider-Genentech Lobbying Group Boosts Spending, Adds Members

340B Working Table
340B Working Table, a lobbying group formed by 340B providers and drugmaker Genentech, has increased spending and added new members.
Genentech, Sanford Health, and Carolina Health Centers’ 340B reform group, 340B Working Table, spent $110,000 on lobbying and gained eight [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

4 Ways Hospital Pharmacies Can Unlock Financial Stability

SPONSORED CONTENT

With so many challenges facing health systems today — from 340B contract pharmacy restrictions to drug shortages, labor issues, and ever-rising costs — revenue integrity has become essential to financial stability.

With huge increases in drug expenditures from pre-pandemic levels, health systems must

Read More »

New House Speaker’s 340B Stance Unclear But Supported 340B Hospitals in 2017 Bill

Mike Johnson
New U.S. House Speaker Mike Johnson (R-La.) has received campaign donations from multiple 340B program stakeholders.
Rep. Mike Johnson (R-La.), the new speaker of the U.S. House, has received campaign donations from multiple 340B stakeholders but [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK Adds Drug to Contract Pharmacy Restriction List

GSK headquarters
GSK was one of two drugmakers to issue refunds to 340B covered entities, according to notices posted on a government regulatory site.
GlaxoSmithKline (GSK) recently restricted 340B pricing on Jesduvroq, an anemia treatment, when providers dispense it through contract pharmacies. GSK contractor [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »